Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer

Dr. Benner is a medical oncologist with extensive experience in drug development. He joins OncoMed from PDL BioPharma (formerly Protein Design Labs) where he served as Senior Vice President and Chief Medical Officer. While at PDL BioPharma, Dr. Benner oversaw all clinical development activities, including international clinical trials for a number of PDL’s monoclonal antibody drug candidates at all stages of development. Previous to his work at PDL, Dr. Benner held a series of positions of increasing responsibility at Bristol Myers Squibb. While there, he held leadership roles in clinical oncology, drug development and licensing, culminating in his position as a Vice President in the company’s Pharmaceutical Research Institute.

Prior to his work with industry, Dr. Benner held faculty appointments at the University of North Carolina and the University of Texas M.D. Anderson Cancer Center. He received his M.D. from the University of Missouri-Columbia and completed his medical training in internal medicine at the University of Texas-San Antonio. He went on to complete his medical oncology training at the Johns Hopkins University, where he also earned an M.H.S. in Clinical Epidemiology. Dr. Benner has been an author or co-author on more than fifty peer-review publications and is an active member of both the American Society of Clinical Oncology and the American Association for Cancer Research.